Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-10,800
Closed -$106K 5771
2025
Q2
$106K Buy
+10,800
New +$89.4K ﹤0.01% 4151
2024
Q2
Sell
-19,800
Closed -$230K 4666
2024
Q1
$230K Buy
+19,800
New +$219K ﹤0.01% 3638
2023
Q4
Sell
-13,900
Closed -$215K 4673
2023
Q3
$215K Buy
+13,900
New +$233K ﹤0.01% 3681
2023
Q2
Sell
-12,600
Closed -$188K 4422
2023
Q1
$188K Buy
+12,600
New +$164K ﹤0.01% 3445

Other funds holding ETNB

Wolverine Trading's ETNB Position: Q1 2025 in Review

Wolverine Trading sold out of 89bio (ETNB) in Q1 2025, closing a stake of 12,354 shares — an estimated $96.2K sold.

Wolverine Trading first reported a position in ETNB in Q4 2024 and held it in 1 quarter. The position peaked at $96.2K in Q4 2024. 186 funds tracked by Wall St. Rank hold ETNB as of Q1 2025.

  • Wolverine Trading reported no remaining 89bio position as of Q1 2025 after selling out during the quarter.
  • Wolverine Trading sold 12,354 89bio shares in Q1 2025, an estimated $96.2K.
  • Wolverine Trading first reported a position in 89bio in Q4 2024 and held it in 1 quarter.
  • Wolverine Trading's 89bio position peaked at $96.2K in Q4 2024.
  • 186 funds tracked by Wall St. Rank held 89bio as of Q1 2025.

Based on Wolverine Trading's 13F filing for Q1 2025, filed 15 May 2025.